Abnormal serum lysophospholipids in multiple myeloma patients

Takayo Sasagawa*, Misako Okita, Jun Murakami, Tsutomu Kato, Akiharu Watanabe

*この論文の責任著者

研究成果: ジャーナルへの寄稿学術論文査読

89 被引用数 (Scopus)

抄録

Lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA) mediate various kinds of biological activities and play an important role in cellular signal transduction. We analyzed serum phospholipids obtained from 16 multiple myeloma (MM) patients and observed that serum LPA level was significantly higher in MM patients (5.3 ± 0.5 nmol/mL) than in normal controls (1.7 ± 0.3 nmol/mL). LPC level was also higher than that in normal controls, and it correlated significantly with the concentration of LPA (r = 0.678, P < 0.01). In MM patients, palmitic acid/linoleic acid ratios in phosphatidylcholine and LPC were higher than those in normal controls. In the 12-mon follow-up study of two patients with the immune globulin G type, we recognized that the increase of LPC, LPA, and arachidonic acid/linoleic acid ratio in phosphatidylinositol corresponded with a decline in the serum albumin level and choline esterase activity.

本文言語英語
ページ(範囲)17-21
ページ数5
ジャーナルLipids
34
1
DOI
出版ステータス出版済み - 1999

ASJC Scopus 主題領域

  • 生化学
  • 有機化学
  • 細胞生物学

フィンガープリント

「Abnormal serum lysophospholipids in multiple myeloma patients」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル